iCAD (NASDAQ:ICAD) Earns Sell Rating from Analysts at StockNews.com

Analysts at StockNews.com began coverage on shares of iCAD (NASDAQ:ICAD) in a research note issued on Monday. The firm set a “sell” rating on the technology company’s stock.

Several other brokerages have also recently issued reports on ICAD. Laidlaw reissued a “hold” rating on shares of iCAD in a research report on Thursday, April 17th. BTIG Research downgraded iCAD from a “buy” rating to a “neutral” rating in a research note on Wednesday, April 16th. Finally, Craig Hallum downgraded iCAD from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 16th.

iCAD Price Performance

iCAD stock opened at $3.63 on Monday. iCAD has a one year low of $1.18 and a one year high of $3.78. The stock has a market capitalization of $99.63 million, a PE ratio of -27.92 and a beta of 1.35. The business’s fifty day moving average is $2.52 and its 200 day moving average is $2.32.

iCAD (NASDAQ:ICAD) last announced its earnings results on Wednesday, March 19th. The technology company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.05) by $0.02. The business had revenue of $5.41 million for the quarter, compared to analysts’ expectations of $4.72 million. iCAD had a negative return on equity of 15.65% and a negative net margin of 17.81%.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in ICAD. waypoint wealth counsel raised its stake in iCAD by 44.0% during the 4th quarter. waypoint wealth counsel now owns 14,400 shares of the technology company’s stock valued at $26,000 after purchasing an additional 4,400 shares during the period. Thompson Davis & CO. Inc. bought a new stake in iCAD during the 4th quarter valued at approximately $31,000. PKS Advisory Services LLC bought a new stake in iCAD during the 4th quarter valued at approximately $53,000. Wells Fargo & Company MN raised its stake in iCAD by 51.3% during the 4th quarter. Wells Fargo & Company MN now owns 39,542 shares of the technology company’s stock valued at $72,000 after purchasing an additional 13,402 shares during the period. Finally, Integrated Wealth Concepts LLC bought a new stake in iCAD during the 4th quarter valued at approximately $92,000. Institutional investors own 24.61% of the company’s stock.

About iCAD

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.